Seòmar agus comataidhean

The review for specialist interventions for managing chronic non-malignant pain in adults was commissioned by Scottish Government but is being led by the Scottish Health Technologies Group (SHTG), part of Healthcare Improvement Scotland (HIS). HIS and SHTG operate independently and neither the Pain Management Taskforce or the Scottish Government have a role in undertaking the review.

SHTG provides evidence-based advice to NHSScotland on health technologies to support informed decision making that improves health and care for people in Scotland. Its advice is underpinned by Health Technology Assessment (HTA) methodology which is a formal, internationally recognised, systematic and transparent process that considers the best available evidence. This includes clinical effectiveness, safety, cost-effectiveness, and the views of patients, healthcare professionals, and wider system implications.

SHTG have determined that they will make recommendations on the following four questions:

1. Is radiofrequency denervation effective, safe and cost effective for treating chronic non-malignant joint pain in adults?

2. Are injections (spinal axial blocks, sacroiliac joint injections, facet joint injections) with or without steroids effective, safe and cost effective treatment options for adults with chronic non-malignant pain?

3. Are lidocaine intravenous infusions effective, safe and cost effective for treating chronic non-malignant pain in adults?

4. What are patient views and experiences of chronic pain treatment in specialist secondary care settings?

The findings will be published on their website and are currently anticipated to be published on 28 November 2025. You can find more information here: Specialist interventions for managing chronic non-malignant pain in adults | Scottish Health Technologies Group.

Decisions about the planning and delivery of NHS services, including specialist pain treatments, are the responsibility of individual Health Boards. Boards are expected to consider the available evidence, local population needs and clinical advice when making decisions.

The Scottish Health Technologies Group is currently undertaking an independent review of certain specialist interventions for chronic pain. Their findings, expected on 28 November 2025, will support informed decision-making across NHS Scotland.

Public Health Scotland provide quarterly updates of immunisation uptake rates for children in Scotland. The most recent release was published on 24 June 2025 and provides uptake statistics for all childhood vaccines, including: the measles, mumps and rubella (MMR) vaccine; the 6 in 1 vaccine (which protects against whooping cough, polio, tetanus, haemophilus influenzae type B and hepatitis B); and the meningitis B vaccine. The report can be found at the following link: Childhood immunisation statistics Scotland - quarter and year ending 31 March 2025 - Childhood immunisation statistics Scotland - Publications - Public Health Scotland

Quarterly childhood immunisation rates across Scotland remain high, reflecting both the hard work and commitment of our colleagues in the NHS and the recognition of the benefits of vaccination.

However, the Scottish Government is aware that there are decreases in uptake compared with previous years, a trend which has been observed globally. We are working with Public Health Scotland and Health Boards to increase vaccination uptake, address health inequalities and support those eligible for vaccination.

Scottish Government officials continue to work closely with colleagues across the four UK nations to ensure cooperation and, where appropriate, alignment on vaccination policy, but we have received no specific information from the UK Government regarding measles deaths in England.

While Childhood immunisation rates in Scotland remain high, we are working with Public Health Scotland and the NHS to increase vaccination uptake in communities across the country. Measles is a highly infectious disease and can lead to serious and potentially life-threatening complications. The MMR vaccine is safe, and it is vital that all those eligible receive both doses of the vaccination, especially because of the current global threat of measles to international and domestic travellers.

The Scottish Government urges parents and carers to take their children to be vaccinated when invited to do so to enable them to be protected against serious disease, including measles, meningitis and pertussis.

The Lord Advocate has responsibility for the investigation of all sudden, suspicious, accidental and unexplained deaths in Scotland, including the deaths of children. Such investigations are conducted by the Crown Office and Procurator Fiscal Service on behalf of the Lord Advocate and these investigations are carried out independently from Government.

Since April 2022, Health Boards have been responsible for delivering vaccines. The vast majority of adult vaccinations, including flu, Covid, RSV, shingles and pneumococcal are visible to GPs via their GP-IT system.

Currently, childhood and non-routine vaccinations do not automatically flow into GP-IT from the separate systems that record them, but this pre-dates the move from GP to Health Board delivery.

Any associated patient risk is mitigated by Health Boards providing GPs with a list of childhood and non-routine vaccinations they have administered. The Scottish Government funds GPs to manually input these into their GP systems.

There are currently no plans for a Ministerial statement on vaccination.

I refer the member to the answer to question S6W-39386 on 28 July 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

I refer the member to the answer to question S6W-39383 on 28 July 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Highland HSCP are putting in place a mixed-model for vaccinations. GP delivery is expected to be key in some aspects of this model, but the plan is for a collaborative approach rather than one that relies solely on GP delivery.

Oversight of how the mixed model is developed and deployed to deliver local and accessible vaccination and immunisation services in a cost effective way will ultimately remain the responsibility of Highland HSCP.

Health boards are funded to offer vaccination in a way that best suits the needs of their communities, supported by national frameworks, such as Public Health Scotland’s (PHS) 5-year Vaccination and Immunisation Framework and Delivery Plan. This plan specifically sets out that boards should “ensure availability of a range of flexible, responsive, and good-quality immunisation services that meet the needs of all communities, including our rural and island communities”.